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INTRODUCTION

49
Dietary methylamines such as choline, trimethylamine N-oxide (TMAO), 50 phosphatidylcholine (PC) and carnitine are present in a number of foodstuffs, including meat, fish, 51 nuts and eggs. It has long been known that gut bacteria are able to use choline in a fermentation-like 8 Aliquots (2× 375 µL) of sample were fixed in ice-cold 4 % paraformaldehyde for 4 h, washed 186 in sterile phosphate-buffered saline and stored for FISH analysis as described by Martín-Peláez et al. 187 (2008) . Supplementary Table 1 gives details for probes used in this study. Probes were synthesized 188 commercially (MWG-Biotech) and labelled with the fluorescent dye cyanine 3 (Cy3; excitation λ, 189 514 nm; emission λ, 566 nm; fluorescence colour, orange-red). FISH was done as described by 190 Martín-Peláez et al. (2008) . (1983) , who used the medium with crystal violet and bile salts to screen members of the 210 Enterobacteriaceae for TMAO reductase activity. Colonies of isolates able to ferment glucose were 211 red, whereas those able to reduce TMAO were white. Growth curves (OD 600 measured hourly for 10-9 12 h, then at 24 h) were determined for selected isolates grown anaerobically at 37 °C in anaerobic 213 minimal broth [g/L: glucose, 4; bacteriological peptone, 20; NaCl, 5; HCl (Sigma-Aldrich), 214 0.5; resazurin solution (0.25 mg/mL; Sigma-Aldrich), 4 mL; pH 7] with and without 1 % (w/v) 215 TMAO dihydrate. Glucose was substituted by raffinose (Sigma-Aldrich) (Trojanová et al., 2006) in 216 the minimal broth when working with bifidobacteria because of the poor growth of these bacteria on 217 the glucose-based medium. pH and metabolite profiles of culture medium were examined at the end 218 of the growth experiment (i.e. at t 24 ). 
233
In vivo confirmation of metabolic retroconversion 234 First, to confirm in vivo metabolic retroconversion (i.e. microbial conversion of TMAO to 235 TMA, followed by host conversion of TMA to TMAO), we administered isotopically-labelled d 9 -
236
TMAO or saline to mice that had or had not been treated with a broad-spectrum antibiotic cocktail for 237 14 days to suppress the gut microbiota (Tang et al., 2013) . Reduction of d 9 -TMAO to d 9 -TMA was 238 quantified in urine by UPLC-MS/MS up to 6 h after d 9 -TMAO gavage, together with unlabelled 239 TMA and TMAO potentially produced from dietary sources ( Fig. 1) .
10
In the absence of antibiotics, d 9 -TMAO was converted to d 9 -TMA within 2 h of gavage. This 241 conversion was dramatically reduced, leading to a significantly lower concentration of d 9 -TMA and a 242 higher concentration of d 9 -TMAO, when the gut microbiota was suppressed by antibiotics ( Fig. 1A- 
243
D). We noted that in the absence of antibiotics all animals excreted approximately three times higher 244 levels of urinary unlabelled TMA than TMAO ( Fig. 1E-H) , corresponding to constitutively low 245 FMO3 activity in mice (Zhang et al., 2007) . Levels of unlabelled TMAO/TMA were not significantly 246 different from one another in the control and d 9 -TMAO-fed animals, while antibiotic treatment 247 significantly reduced the amount of both TMAO and TMA (Fig. 1E, F) . Bioavailability of unlabelled 248 TMAO/TMA, as assessed by area under the curve (AUC), was significantly reduced by antibiotic 249 treatment in both saline and d 9 -TMAO-gavaged animals, with almost no TMA detected in either 250 experimental group (Fig. 1G, H) .
252
Effect of TMAO on human gut bacteria within a mixed system 253 After in vivo validation of the role of the gut microbiota in metabolic retroconversion, we 254 analysed the effect of TMAO on the faecal microbiota in an anaerobic batch-culture fermentation 255 system. Fermenter vessels filled with the glucose-containing medium supplemented or not with 1 % 256 (w/v) TMAO were inoculated with faecal slurries from three healthy donors and monitored for 9 h.
257
With the exception of enhanced growth of the Enterobacteriaceae (probe Ent), the presence of 258 TMAO in the medium had no statistically significant effect on the growth of bacteria within the 259 fermentation systems at 9 h ( Fig. 2A, Supplementary Figure 1 ).
260
Huge variability, as measured by 1 H-NMR, was observed in the amount of TMA and DMA 261 produced by gut bacteria in the TMAO-containing fermentation systems, with the concentrations of 262 both metabolites increasing steadily from 0 to 9 h and differing significantly (P < 0.05) from the 263 control systems (Fig. 2B) . The amount of TMAO in the systems was seen to decrease at 8 h.
264
Correlation of metabolite and FISH data demonstrated Clostridium clusters I and II 265 (Chis150), Enterobacteriaceae (Ent), bifidobacteria (Bif164) and coriobacteriia (Ato291) were 266 associated with TMA, acetate, ethanol and lactate (Fig. 2C) . The Betaproteobacteria (Bet42a) were 267 anti-correlated with TMA, acetate, ethanol and lactate, which is unsurprising given this was the only 268 11 group of bacteria whose representation decreased in the fermentation systems over the course of the 269 experiment (Supplementary Figure 1, Fig. 2C) . The Enterobacteriaceae and clostridia were 270 positively correlated with DMA production. The lactic acid bacteria (Lab158) were not significantly 271 correlated with any of the metabolites in the mixed culture. 
285
To determine whether these isolates were converting TMAO to TMA but a low level, we 286 examined the growth of all isolates in liquid culture and metabolites in the spent medium using NMR.
287
The growth of the Enterobacteriaceae was most greatly affected by the presence of TMAO in the 288 medium, with a faster, longer-lasting exponential phase than for the same isolates grown in the 289 control medium (Fig. 3A) . pH of the spent medium (after 24 h) when Enterobacteriaceae were grown 290 in the presence of TMAO increased from a mean of 4.7 ± 0.3 (for the control) to 7.6 ± 0.3 (n = 20)
291
(the change in pH is what causes the colonies to appear white on TMAO-containing agar). The 292 growth of lactic acid bacteria, including Enterococcus and Streptococcus (Fig. 3A) spp., was 293 enhanced in the presence of TMAO, but not to the same extent as seen for the Enterobacteriaceae.
294
There was no significant difference (P = 0.27, t test) in the pH of the spent medium for these bacteria 295 after 24 h (mean 4.67 ± 0.9 compared with 4.33 ± 0.27 for the control). The growth of members of 12 Clostridium cluster I (e.g. Clostridium perfringens, Fig. 3A ) was not enhanced in the presence of 297 TMAO, though some of these bacteria changed the colour of both the control and TMAO-containing 298 plates yellow during their growth. The pH of the spent liquid medium confirmed this observation to 299 be due to the alkalinity of the media in the control and TMAO-containing media after 24 h incubation: 300 e.g. Clostridium sporogenes D1(9) (pH 6.25 compared with 6.76 in the control medium), Clostridium 301 paraputrificum L16-FAA6 (pH 6.45 vs 5.38) and Clostridium perfringens L20-BSM1 (pH 5.56 vs Table 2 ). Members of the families Peptostreptococcaceae (3.72 mM, n = 1), Clostridiaceae (Cluster 307 I) (2.62 ± 1.83 mM, n = 3), Porphyromonadaceae (1.42 mM, n = 1), Bacteroidaceae (1.40 ± 0.31 308 mM, n = 3), Enterococcaceae (1.19 ± 0.05 mM, n = 5), Erysipelotrichaceae (0.94 mM, n = 1;
309
[Clostridium] ramosum), Staphylococcaceae (0.34 mM, n = 1), Streptococcaceae (0.30 ± 0.16 mM, n 310 = 5), Lactobacillaceae (0.17 ± 0.07 mM, n = 2), Pseudomonadaceae (0.12 mM, n = 1) and 311 Bifidobacteriaceae (0.13 ± 0.1 mM, n = 17) produced low levels of TMA from TMAO ( Fig. 3B 
318
Comparison of the amounts of TMA, and co-metabolites, produced by the faecal (n = 7) and 319 caecal (n = 9) isolates of Escherichia coli demonstrated significantly higher amounts of TMA were 320 produced by the caecal isolates compared with the faecal isolates in the TMAO-containing medium 321 ( Fig. 3C) . Escherichia coli of caecal origin produced more TMA than faecal isolates of the same 322 bacterium or other enterobacteria (Hafnia, Citrobacter and Klebsiella spp.) ( Supplementary Table   323 2). The faecal isolates produced more acetate and lactate than the caecal isolates when grown in the 324 13 control medium. Taken together, these results demonstrate the different metabolic capabilities of 325 isolates of Escherichia coli recovered from different regions of the human gut.
327
Lactic acid bacteria produce more lactate in the presence of TMAO
328
Differences were also seen in the amount of lactic acid produced by lactic acid bacteria in the 329 presence and absence of TMAO ( Fig. 3B, D) . In raffinose-containing medium, bifidobacteria 330 produced increased of amounts of lactate when grown in the presence of TMAO (the bifidobacteria 331 grew poorly, if at all, in glucose-containing media). Unlike the bifidobacteria, the Streptococcaceae 332 and Enterococcaceae grew well in the glucose-containing medium and produced over 25 mM lactic 333 acid in the TMAO-containing samples compared with < 5 mM in the control samples ( Fig. 3D) . To 334 the best of our knowledge, this is the first time TMAO has been shown to influence the metabolism of 335 gut bacteria -specifically lactic acid bacteria -without producing appreciable amounts of TMA. 
339
TMAO is a circulating metabolite produced as a direct result of microbial degradation of 340 dietary methylamines in the intestinal tract, and can be readily detected along with its precursor TMA 341 in human urine, blood and skeletal muscle (Wang et al., 2011; Koeth et al., 2013; Tang et al., 2013;  342 Taesuwan et al., 2017) . It worsens atherosclerosis in some mouse models of cardiovascular disease, 343 and is positively correlated with cardiovascular disease severity in humans. Beneficial effects 344 associated with TMAO include potential protection from hyperammonia and glutamate neurotoxicity, 345 alleviation of endoplasmic reticulum stress and improved glucose homeostasis by stimulating insulin 346 secretion by pancreatic cells (Kloiber et al., 1988; Miñana et al., 1996; Dumas et al., 2017) .
347
Over many decades it has been established that choline, PC and carnitine are dietary 348 methylamines that contribute directly to microbiome-associated circulating levels of TMAO found in 349 humans and other animals (e.g. Zeisel et al., 1983; Rebouche et al., 1984; Seim et al., 1985; Wang et 350 al., 2011; Koeth et al., 2013; Tang et al., 2013) . However, TMAO itself is a water-soluble osmolyte 351 found in high abundance in fish. Based on their observations that individuals with trimethylaminuria 352 14 could reduce an oral dose of TMAO to TMA could not detoxify it to TMAO, al-Waiz et al. (1987) 353 suggested the gut microbiota could use TMAO as a substrate, and in those individuals without 354 trimethylaminuria the TMA was re-oxidized in the liver before being excreted in the urine. This led 355 these authors to propose the process of 'metabolic retroversion'. Reference to the literature associated 356 with fish spoilage and recent mining of metagenomic data have predicted members of the 357 Enterobacteriaceae (particularly Escherichia coli and Klebsiella pneumoniae) have the potential to 358 convert TMAO to TMA in the intestinal tract, but this has not been tested in vitro or in vivo to date 359 (Takagi and Ishimoto, 1983; Barrett and Kwan, 1985; Jameson et al., 2016; Borrel et al., 2017;  360 Taesuwan et al., 2017) . Consequently, we instigated this study to demonstrate metabolic 361 retroconversion of TMAO, and to determine the effect of TMAO on the growth and metabolism of 362 human-derived intestinal bacteria in pure and mixed cultures.
363
Through in vivo administration of deuterated TMAO to mice via oral gavage in mice, we 364 unambiguously demonstrated that TMAO is converted to TMA, with this TMA detectable in plasma 365 within 2 h of administration. This conversion was highly dependent on the gut microbiota, as 366 conversion of TMAO to TMA was dramatically reduced when the microbiota was suppressed by 367 treatment of animals with broad-spectrum antibiotics. Even in the presence of antibiotics, there was 368 low-level conversion of TMAO to TMA, suggesting a subpopulation of the microbiota was resistant 369 to the antibiotics used in our experiment. However, administration of a broad-spectrum antibiotic 370 cocktail for 14 days has been demonstrated to be an effective means of suppressing the gut microbiota 371 in studies associated with gut microbial use of dietary methylamines (Tang et al., 2013) .
372
Our in vivo experiment clearly demonstrates the gut microbiota converts TMAO to TMA, and 373 that this TMA is re-oxidized to TMAO, in line with the process of 'metabolic retroversion' defined 
381
Having conducted our in vivo experiment in mice, we examined the ability of a range of 382 human-derived gut bacteria to convert TMAO to TMA. In the mixed microbiota system and in pure 383 cultures, the growth of the Enterobacteriaceae -the main TMA-producers -was quickly affected by 384 the presence of TMAO. This is likely to happen in the human gut also. Consequently, we believe 
392
Of note is the finding that caecal isolates of enterobacteria produce more TMA from TMAO 393 than faecal isolates of the same bacterium. The speed with which TMAO was reduced to TMA by the 394 Enterobacteriaceae in the present study suggests bacterial conversion of TMAO to TMA takes place 395 in the small intestine/proximal colon of humans and small intestine/caecum of mice. It is, therefore, 396 unsurprising that caecal bacteria -representing the microbiota present at the intersection of the small 397 and large intestine -are metabolically more active than their faecal counterparts with respect to 398 TMAO metabolism. This finding is relevant to functional studies of the gut microbiota where gene 399 annotations are based largely on faecal isolates, whose functionalities may be greatly different from 400 those of bacteria in other regions of the human intestinal tract. It has already been demonstrated that 401 the microbiota of the small intestine is enriched for functions associated with rapid uptake and 402 fermentation of simple carbohydrates compared with the faecal microbiota, and that streptococci 403 isolated from this niche are functionally very different from the same bacteria isolated from different 404 habitats (Zoetendal et al., 2012; van den Bogert et al., 2013) . It is, therefore, important we 405 characterize the functions and genomes of bacteria isolated from all regions of the intestinal tract, not 406 just those of faecal bacteria, to gain a true picture of how microbial activity influences host health.
407
Enterobacteriaceae made the greatest contribution to the conversion of TMAO to TMA, both 408 16 in pure culture and in a mixed microbiota. These Gram-negative bacteria are a source of the virulence 409 factor lipopolysaccharide (LPS), which is associated with low-grade inflammation in high-fat-fed 410 mice and elevated plasma levels that define metabolic endotoxaemia (Cani et al., 2007 (Cani et al., , 2008 . High-411 fat feeding has been shown to increase the representation of Enterobacteriaceae in the caecal 412 microbiota of obesity-prone Sprague-Dawley rats (de La Serre et al., 2010) , though this mode of 413 feeding is known to modulate the microbiota of mice independent of obesity (Hildebrandt et al., 414 2009 ). Non-LPS-associated virulence of Enterobacteriaceae, Vibrio cholerae and Helicobacter pylori 415 is increased when these bacteria are grown anaerobically or microaerophilically in the presence of as 416 little as 5-10 mM TMAO (Ando et al., 2007; Lee et al., 2012; Paiva et al., 2009; Wu et al., 2017) , number of these bacteria are facultative anaerobes able to grow over a range of conditions, and whose 426 representation is increased in obese, and cirrhotic patients (Le Chatelier et al., 2013; Qin et al., 2014) . 
432
With respect to the lactic acid bacteria, it is important to note that our mixed culture work did 433 not highlight these as being relevant to TMAO metabolism. This is unsurprising given these bacteria 434 do not produce large quantities of TMA from TMAO. However, we have shown their metabolism is 435 affected by presence of TMAO in growth medium, and the increased lactate they produce in its presence may contribute to cross-feeding associated with short-chain fatty acid production (Hoyles 437 and Wallace, 2010). It is difficult to determine relevance of correlations from mixed microbial 438 ecosystems in the absence of isotope labelling or pure culture work: i.e. correlation does not equate 439 with causation. As an example, three (Clostridium clusters I and II, bifidobacteria, coriobacteriia) of 440 the four groups of bacteria correlated with TMA production in our fermentation study did not produce 441 notable quantities of TMA from TMAO based on our pure culture work. Therefore, correlating 442 microbiota and metabolite data derived from complex systems will not give a true picture of which 443 members of microbiota contribute to specific metabolic processes, and work with pure cultures is 444 required to supplement functional studies to increase our understanding of poorly understood 445 microbially driven metabolic processes within the human gut.
446
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